GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (OTCPK:NVZMY) » Definitions » Cash, Cash Equivalents, Marketable Securities

Novonesis AS (Novonesis AS) Cash, Cash Equivalents, Marketable Securities : $169 Mil (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Novonesis AS Cash, Cash Equivalents, Marketable Securities?

Novonesis AS's quarterly cash, cash equivalents, marketable securities increased from Jun. 2023 ($161.67 Mil) to Sep. 2023 ($170.44 Mil) but then stayed the same from Sep. 2023 ($170.44 Mil) to Dec. 2023 ($169.13 Mil).

Novonesis AS's annual cash, cash equivalents, marketable securities increased from Dec. 2021 ($157.73 Mil) to Dec. 2022 ($159.62 Mil) and increased from Dec. 2022 ($159.62 Mil) to Dec. 2023 ($169.13 Mil).


Novonesis AS Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Novonesis AS's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis AS Cash, Cash Equivalents, Marketable Securities Chart

Novonesis AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 107.99 212.58 157.73 159.62 169.13

Novonesis AS Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 159.62 170.31 161.67 170.44 169.13

Novonesis AS Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Novonesis AS  (OTCPK:NVZMY) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Novonesis AS Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Novonesis AS's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis AS (Novonesis AS) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (OTCPK:NVZMY) » Definitions » Cash, Cash Equivalents, Marketable Securities
Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Novonesis AS (Novonesis AS) Headlines

From GuruFocus

2 Holdings to Reduce Based on Analyst Recommendations

By Alberto Abaterusso Alberto Abaterusso 11-06-2019

Novozymes A/S's Dividend Analysis

By GuruFocus Research 10-19-2023

Not Just Yogurt Anymore

By PRNewswire 10-26-2023